Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors

Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors

<b>Background/Objectives</b>: Emerging evidence suggests an association between glucagon-like peptide-1 (GLP-1) receptor agonists and sodium–glucose co-transporter 2 (SGLT2) inhibitors with altered risk of damage in the inner ear system. However, limited research exists on the relationsh...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiann-Jy Chen, Chih-Wei Hsu, Chao-Ming Hung, Chih-Sung Liang, Kuan-Pin Su, Andre F. Carvalho, Brendon Stubbs, Yen-Wen Chen, Tien-Yu Chen, Wei-Te Lei, Bing-Yan Zeng, Ping-Tao Tseng
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceuticals
Subjects:
network meta-analysis
GLP-1 receptor agonist
SGLT2 inhibitor
exendin-4
hearing loss
lixisenatide
Online Access:https://www.mdpi.com/1424-8247/18/5/735
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/5/735

Similar Items